59th Medical Wing at the Wilford Hall Ambulatory Surgical Center (WHASC)
The 59th Medical Wing Chief Scientist provides the strategic vision, direction, oversight, project management support and technical resources to advance medical modernization efforts with a unique focus on research activities.
59th Medical Wing at the Wilford Hall Ambulatory Surgical Center (WHASC)
The 59th Medical Wing Chief Scientist provides the strategic vision, direction, oversight, project management support and technical resources to advance medical modernization efforts with a unique focus on research activities.
59th Medical Wing at the Wilford Hall Ambulatory Surgical Center (WHASC)
The 59th Medical Wing Chief Scientist provides the strategic vision, direction, oversight, project management support and technical resources to advance medical modernization efforts with a unique focus on research activities.
As one of the world’s leading independent biomedical research institutions, Texas Biomedical Research Institute is dedicated to advancing the health of our global community through innovative biomedical research.
Principal Investigator(s)
Piergallini, Tucker
Funded by
Douglass Foundation
Increased inflammation affects the immune response to Mycobacterium tuberculosis (M.tb) infection in old and young mice in ways not yet understood. The project objective is to determine the mechanisms in which inflammation influences the response to early M.tb infection in young and old mice. The goal of the project is to determine ways inflammation can be modulated with anti-inflammatory treatment to improveM.tb infection outcome in young and old mice, and to apply this knowledge to benefit tuberculosis disease outcome in elderly persons and persons with increased inflammation.
The University of Texas at San Antonio is an emerging Tier One research institution with nearly 29,000 students.
Principal Investigator(s)
Lopez-Ribot, Jose
Wormley, Floyd
Funded by
NIH Natl Inst of Allergy/Infectious Dise
Fungal infections constitute a major threat to an ever expanding spectrum of immune- and medically-compromised patients. The opportunistic pathogenic fungi Candida spp., Aspergillus spp. and Cryptococcus neoformans are among the most common etiologic agents of mycoses; but infections caused by other yeasts and moulds are on the rise as advances in modern medicine prolongs lives resulting in increasingly susceptible and vulnerable patients.
